Product Code: ETC044704 | Publication Date: Jun 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The India Companion Animal Specialty Drugs Market was estimated to be around US$ 144.2 million in 2025 and is projected to reach a value of US$ 382.4 million by 2031, exhibiting a CAGR of 16.8% during the forecast period (2025-2031). The growing awareness regarding animal healthcare, rising demand for animal-derived food products, increasing pet adoption rates, growing number of veterinary practitioners are some of the major factors driving the market growth in India.
Growing Awareness Regarding Animal Healthcare ? With increasing public interest and awareness related to animal health among pet owners in India has resulted into increased expenditure on companion animals? healthcare services including specialty drugs which is expected to drive the market growth over the forecast period. Rising Demand for Animal Derived Food Products ? The rising demand for meat-based products such as beef, pork and poultry has led to an increase in livestock production across India due to which there is an increased usage of veterinary medicines particularly antibiotics which can lead to drug resistance issues if used recklessly therefore speciality drugs are extensively becoming popular leading towards market growth over time. Increasing Pet Adoption Rates ? In recent years there has been an increase in pet adoption rates coupled with rise in discretionary income that provides various opportunities for improvement of pets lifestyle through healthy diet along with proper medical care hence providing numerous opportunities for medical product vendors operating within this space thus propelling market growth significantly going forward.
High Cost Associated with Specialty Drugs - High cost associated with these specialized drugs may act as a restraint factor while hindering its widespread use amongst veterinarians limiting its potential applications thereby posing challenge towards overall market expansion over time ahead. Lack Of Skilled Veterinarians? A lack skilled veterinarians who have access & knowledge about advanced treatments options available may pose serious challenges before industry players hampering their efforts towards development & commercialization new innovative quality products eventually affecting overall profitability margins adversely going forward .
Some key players operating within this space include Boehringer Ingelheim GmbH; Zoetis Services LLC.; Merck & Co., Inc.; Eli Lilly and Company; Bayer AG; Vetoquinol SA; Virbac SA ; Elanco Animal Health ; Novartis AG ; Nutreco Nv etc..
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Companion Animal Specialty Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Companion Animal Specialty Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Companion Animal Specialty Drugs Market - Industry Life Cycle |
3.4 India Companion Animal Specialty Drugs Market - Porter's Five Forces |
3.5 India Companion Animal Specialty Drugs Market Revenues & Volume Share, By Product Types, 2021 & 2031F |
3.6 India Companion Animal Specialty Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Companion Animal Specialty Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Companion Animal Specialty Drugs Market Trends |
6 India Companion Animal Specialty Drugs Market, By Types |
6.1 India Companion Animal Specialty Drugs Market, By Product Types |
6.1.1 Overview and Analysis |
6.1.2 India Companion Animal Specialty Drugs Market Revenues & Volume, By Product Types, 2021-2031F |
6.1.3 India Companion Animal Specialty Drugs Market Revenues & Volume, By Anti-Inflammatory Drugs, 2021-2031F |
6.1.4 India Companion Animal Specialty Drugs Market Revenues & Volume, By Vaccines, 2021-2031F |
6.1.5 India Companion Animal Specialty Drugs Market Revenues & Volume, By Antibiotics, 2021-2031F |
6.1.6 India Companion Animal Specialty Drugs Market Revenues & Volume, By Animal Feed Additives, 2021-2031F |
6.1.7 India Companion Animal Specialty Drugs Market Revenues & Volume, By Parasiticides, 2021-2031F |
6.1.8 India Companion Animal Specialty Drugs Market Revenues & Volume, By Skin Care Products, 2021-2031F |
6.2 India Companion Animal Specialty Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
7 India Companion Animal Specialty Drugs Market Import-Export Trade Statistics |
7.1 India Companion Animal Specialty Drugs Market Export to Major Countries |
7.2 India Companion Animal Specialty Drugs Market Imports from Major Countries |
8 India Companion Animal Specialty Drugs Market Key Performance Indicators |
9 India Companion Animal Specialty Drugs Market - Opportunity Assessment |
9.1 India Companion Animal Specialty Drugs Market Opportunity Assessment, By Product Types, 2021 & 2031F |
9.2 India Companion Animal Specialty Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Companion Animal Specialty Drugs Market - Competitive Landscape |
10.1 India Companion Animal Specialty Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Companion Animal Specialty Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |